Angiographybased quantitative flow ratio for functional assessment of intracranial atherosclerotic disease

Kangmo Huang1, Haotao Li2, Shengxian Tu3

  • 1Department of Neurology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Insights

Quantitative flow ratio (QFR) effectively identifies symptomatic intracranial atherosclerotic stenosis (ICAS), outperforming traditional stenosis measurements. A novel risk model using QFR aids in stratifying patients with ICAS for better stroke prevention.

Area of Science:

  • Neuroscience
  • Cardiovascular Research
  • Medical Imaging

Background:

  • Intracranial atherosclerotic stenosis (ICAS) is a significant cause of stroke with high recurrence rates.
  • Accurate assessment of ICAS functional significance is crucial for personalized treatment and improved outcomes.
  • Current methods may not fully capture the hemodynamic impact of ICAS.

Purpose of the Study:

  • To evaluate the hemodynamic significance of ICAS using quantitative flow ratio (QFR).
  • To develop and validate a risk stratification model for ICAS patients.
  • To compare the diagnostic performance of QFR against traditional stenosis measurements.

Main Methods:

  • Retrospective enrollment of patients with moderate to severe middle cerebral artery stenosis.
  • Hemodynamic assessment using Murray law-based quantitative flow ratio (μQFR).
  • Development and validation of multivariate logistic regression models and a nomogram incorporating μQFR and conventional risk factors.

Main Results:

  • Symptomatic lesions were identified in 76.0% of 412 eligible patients.
  • μQFR demonstrated superior discrimination of culprit lesions compared to angiographic stenosis severity (AUC 0.726 vs 0.631).
  • The μQFR-inclusive model showed improved performance in risk stratification (AUC 0.850) with good calibration and discrimination.

Conclusions:

  • μQFR is significantly associated with symptomatic ICAS and superior to stenosis severity in identification.
  • The developed nomogram effectively discriminates symptomatic lesions in ICAS patients.
  • This μQFR-based nomogram may serve as a valuable tool for ICAS patient risk stratification.
Abstract

Related Concept Videos